Lipidomic Predictors of Coronary No-Reflow

Lipidomic Predictors of Coronary No-Reflow

The ‘no-reflow’ phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is a serious complication among acute ST-segment elevation myocardial infarction (STEMI) patients. Herein, a comprehensive lipidomics approach was used to quantify over 300 distinct molecular species in circulati...

Full description

Bibliographic Details
Main Authors:	Arun Surendran, Umar Ismail, Negar Atefi, Ashim K. Bagchi, Pawan K. Singal, Ashish Shah, Michel Aliani, Amir Ravandi
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Metabolites
Subjects:	no-reflow lipidomics sphingomyelin ether-lipids
Online Access:	https://www.mdpi.com/2218-1989/13/1/79

Similar Items

Defining Acute Coronary Syndrome through Metabolomics
by: Arun Surendran, et al.
Published: (2021-10-01)

Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival
by: Preeti Purwaha, et al.
Published: (2018-07-01)

Nonalcoholic fatty liver disease stratification by liver lipidomics
by: Olga Vvedenskaya, et al.
Published: (2021-01-01)

Effect of no-reflow/reflow on P-wave time indexes in patients with acute myocardial infarction undergoing percutaneous coronary intervention
by: Ahmet Karakurt, et al.
Published: (2020-01-01)

Treatment in no-reflow after percutaneous coronary intervention : A case series
by: Daohui Gan, et al.
Published: (2021-10-01)

Treatment Outcomes in STEMI Patients With No/Slow-Reflow Phenomenon, Depending on Age
by: G. V. Sazanov, et al.
Published: (2023-11-01)

Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum
by: Padmajan Sabin, et al.
Published: (2017-04-01)

Lipidomic Analysis of Cervicovaginal Fluid for Elucidating Prognostic Biomarkers and Relevant Phospholipid and Sphingolipid Pathways in Preterm Birth
by: Se Hee Hong, et al.
Published: (2023-01-01)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
by: Luca Grancini, et al.
Published: (2023-03-01)

Integrated lipidomics and RNA sequencing analysis reveal novel changes during 3T3-L1 cell adipogenesis
by: Yangli Pei, et al.
Published: (2022-05-01)

Dilation of the Infarct-Related Coronary Artery to Reduce the Incidence of the No-Reflow Phenomenon in STEMI Patients
by: G. V. Sazanov, et al.
Published: (2023-08-01)

No-reflow fenomeniyle ilişkili nadir yerleşimli miyokardiyal köprüleme
by: Mehmet Kabukçu, et al.
Published: (2013-06-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Maryam Shakiba, et al.
Published: (2020-04-01)

Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis
by: Elmira Jafari Afshar, et al.
Published: (2024-01-01)

Lipid signatures of chronic pain in female adolescents with and without obesity
by: Paula A. Gonzalez, et al.
Published: (2022-08-01)

Phospholipids in lipoproteins: compositional differences across VLDL, LDL, and HDL in pregnant women
by: Sebastian Rauschert, et al.
Published: (2019-01-01)

Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Hesham Refaat, et al.
Published: (2021-01-01)

Association Between Bifurcation Angle and Coronary No-reflow Following Primary Percutaneous Coronary Intervention in Patients
by: Ömer Taşbulak, et al.
Published: (2021-12-01)

Efficacy of sodium nitroprusside combined with verapamil in the treatment of no-reflow during coronary interventional therapy
by: Chao Gao, et al.
Published: (2019-01-01)

Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
by: Barış Yaylak, et al.
Published: (2018-12-01)

TENECTEPLASE AS A NEW MEDICATION IN MANAGING NO-REFLOW
by: Milan Živković, et al.
Published: (2012-03-01)

No-reflow phenomenon and reperfusion injury. Mechanisms and treatment
by: M. Yu. Gilyarov, et al.
Published: (2022-03-01)

Influence of Multiple Reflows and Surface Finishes on Solder Joint Resistivity
by: Dzivy Daniel, et al.
Published: (2021-12-01)

Investigations of Infrared Desktop Reflow Oven with FPCB Substrate during Reflow Soldering Process
by: Muhammad Iqbal Ahmad, et al.
Published: (2021-07-01)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
by: Nian-Peng Song, et al.
Published: (2020-10-01)

Predictors of No-reflow Phenomenon Development in Patients Presenting with ST Segment Elevated Myocardial Infarction and Treated with Primary Percutaneous Coronary Intervention
by: Esra Dönmez, et al.
Published: (2023-12-01)

The Predictive Value of CHADS-VASC Score in No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention
by: Ali Farahe, et al.
Published: (2022-11-01)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2018-07-01)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
by: Marcin Kożuch, et al.
Published: (2022-12-01)

Removal of the main inflorescence to induce reflowering of loquat
by: Jiangrong Peng, et al.
Published: (2022-01-01)

Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids
by: Iris D. Zelnik, et al.
Published: (2020-10-01)

Contribution of Ni microalloying to Cu dissolution in In–35Sn/Cu solder joints after multiple reflows
by: M.S. Chang, et al.
Published: (2023-09-01)

“No-Reflow” Phenomenon: A Contemporary Review
by: Gianmarco Annibali, et al.
Published: (2022-04-01)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Ali Mohammed Kareem Al-Jabari, et al.
Published: (2017-09-01)

Thrombolysis for Prevention of Cerebral No-Reflow After Cardiopulmonary Resuscitation
by: K. -A. Hossmann, et al.
Published: (2009-04-01)

Reflow Soldering Capability Improvement by Utilizing TaN Interfacial Layer in 1Mbit RRAM Chip
by: Peng Yuan, et al.
Published: (2022-03-01)

The Effect Of Void Formation On The Reliability Of ED-XRF Measurements In Lead-Free Reflow Soldering
by: Koncz-Horváth D., et al.
Published: (2015-06-01)

Understanding the Effect of Reflow Profile on the Metallurgical Properties of Tin–Bismuth Solders
by: Karel Dušek, et al.
Published: (2022-01-01)

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention
by: Wang Y, et al.
Published: (2020-02-01)